Al's Comment:
This is the drug that used to be called Onc-201. It finally got approved as the first drug ever approved for diffuse midline glioma!
The Musella Foundation supported the development of this drug from the start!
Posted on: 08/06/2025
Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
Click HERE to return to brain tumor news headlines.